Want to hire this expert for a project? Request a quote for free.
Profile Details
Create Project
USD 200 /hr
Hire Christopher Z.
United States
USD 200 /hr
Therapeutic and Diagnostic Consulting | Expert in cancer immunology
Profile Summary
Subject Matter Expertise
Services
Research
Feasibility Study,
Technology Scouting,
Fact Checking,
Scientific and Technical Research,
Systematic Literature Review
Consulting
Healthcare Consulting,
Operations Consulting,
Scientific and Technical Consulting,
Regulatory Consulting
Data & AI
Statistical Analysis,
Image Processing,
Image Analysis,
Data Visualization,
Data Processing,
Data Insights
Work Experience
Consultant
Freelance Consulting
September 2023 - Present
Scientist
University of Wisconsin Madison
September 2017 - Present
Manager Research
Elephas Biosciences
January 2022 - September 2023
Postdoctoral Fellow
University of Wisconsin Madison
September 2014 - August 2017
Education
PhD - Cancer Biology (Oncology)
University of Wisconsin Madison
July 2009 - August 2014
BSc - Biochemistry
University of Wisconsin Madison
September 2007 - May 2009
AAS
University of Wisconsin - Waukesha Co.
September 2005 - May 2007
Certifications
Publications
PREPRINT
Christopher D. Zahm, Viswa T. Colluru, Sean J. McIlwain, Irene M. Ong, Douglas G. McNeel (2023). Supplementary Figures and Legends from TLR Stimulation during T-cell Activation Lowers PD-1 Expression on CD8<sup>+</sup> T Cells .
Christopher D. Zahm, Viswa T. Colluru, Sean J. McIlwain, Irene M. Ong, Douglas G. McNeel (2023). Data from TLR Stimulation during T-cell Activation Lowers PD-1 Expression on CD8<sup>+</sup> T Cells .
Christopher D. Zahm, Viswa T. Colluru, Sean J. McIlwain, Irene M. Ong, Douglas G. McNeel (2023). Supplementary Figures and Legends from TLR Stimulation during T-cell Activation Lowers PD-1 Expression on CD8<sup>+</sup> T Cells .
JOURNAL ARTICLE
Melissa Gamat-Huber, Donghwan Jeon, Laura E. Johnson, Jena E. Moseman, Anusha Muralidhar, Hemanth K. Potluri, Ichwaku Rastogi, Ellen Wargowski, Christopher D. Zahm, Douglas G. McNeel(2020). Treatment Combinations with DNA Vaccines for the Treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC) . Cancers. 12. (10). p. 2831. {MDPI} {AG}
Christopher D. Zahm, Viswa T. Colluru, Sean J. McIlwain, Irene M. Ong, Douglas G. McNeel (2018). TLR Stimulation during T-cell Activation Lowers PD-1 Expression on CD8+ T Cells . Cancer Immunology Research.
Zahm CD, Colluru VT, McIlwain SJ, Ong IM, McNeel DG(2018). TLR Stimulation during T-cell Activation Lowers PD-1 Expression on CD8+ T Cells . Cancer immunology research.
McNeel DG, Eickhoff JC, Wargowski E, Zahm C, Staab MJ, Straus J, Liu G(2018). Concurrent, but not sequential, PD-1 blockade with a DNA vaccine elicits anti-tumor responses in patients with metastatic, castration-resistant prostate cancer . Oncotarget.
Zahm CD, Colluru VT, McNeel DG(2017). Vaccination with High-Affinity Epitopes Impairs Antitumor Efficacy by Increasing PD-1 Expression on CD8+ T Cells . Cancer immunology research.
Zahm CD, Colluru VT, McNeel DG(2017). DNA vaccines for prostate cancer . Pharmacology & therapeutics.
Colluru VT, Zahm CD, McNeel DG(2016). Mini-intronic plasmid vaccination elicits tolerant LAG3+ CD8+ T cells and inferior antitumor responses . Oncoimmunology.
Zahm CD, Szulczewski JM, Leystra AA, Paul Olson TJ, Clipson L, Albrecht DM, Middlebrooks M, Thliveris AT, Matkowskyj KA, Washington MK, et al.(2016). Advanced Intestinal Cancers often Maintain a Multi-Ancestral Architecture . PloS one.